Product
G-CHOP
2 clinical trials
3 indications
Indication
Diffuse Large B-Cell LymphomaIndication
Cancer of Unknown PrimaryIndication
Follicular LymphomaClinical trial
A Multi-center, Randomized, Double-blind, Controlled, and Parallel Phase III Study to Compare the Efficacy and Safety of GB241 (Recombinant Anti-CD20 Human-Mouse Chimeric Monoclonal Antibody Injection, Experimental Drug) Plus CHOP Versus Rituximab Plus CHOP in Untreated Diffuse Large B-cell Lymphoma (DLBCL) PatientsStatus: Recruiting, Estimated PCD: 2022-08-17
Clinical trial
Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma. A Randomized, Open Label, Phase III Study by Fondazione Italiana Linfomi.Status: Recruiting, Estimated PCD: 2028-07-01